Microbiomic analysis of human gut samples is a beneficial tool to examine the general well-being and various health conditions. The balance of the intestinal flora is important to prevent chronic gut infections and adiposity, as well as pathological alterations connected to various diseases. The evaluation of microbiome data based on next-generation sequencing (NGS) is complex and their interpretation is often challenging and can be ambiguous. Therefore, we developed an innovative approach for the examination and classification of microbiomic data into healthy and diseased by visualizing the data as a radial heatmap in order to apply deep learning (DL) image classification. The differentiation between 674 healthy and 272 type 2 diabetes mellitus (T2D) samples was chosen as a proof of concept. The residual network with 50 layers (ResNet-50) image classification model was trained and optimized, providing discrimination with 96% accuracy. Samples from healthy persons were detected with a specificity of 97% and those from T2D individuals with a sensitivity of 92%. Image classification using DL of NGS microbiome data enables precise discrimination between healthy and diabetic individuals. In the future, this tool could enable classification of different diseases and imbalances of the gut microbiome and their causative genera.
Pandemics challenge the capacity and resilience of healthcare systems around the world. A rapid and effective response to the sudden spread of a pathogen i
The analysis of blood is one of the best possibilities to diagnose and control diseases and deficiency symptoms. Common blood tests that are performed in medical laboratories are time-consuming and work-intensive. In under-developed areas, there is often also a lack of specialised staff and facilities. The development of a mobile microscopic system that contains an automated image analysis and that can be used via a smartphone, could represent a valuable help to improve the diagnostic care, especially in those areas. it aims to enable a very fast, cheap, location- and knowledge-independent application for many use cases.
Background: Leishmaniasis is a vector-borne parasitic disease caused by Leishmania protozoa. The disease manifests in several clinical presentations including cutaneous, mucocutaneous, and visceral leishmaniasis. The diagnosis of leishmaniasis is complex and often requires a combination of clinical assessment, microscopy, serological tests, and molecular techniques especially in immunocompromised cases. However, traditional diagnostic methods have limitations in terms of accuracy, sensitivity, and the expertise required, leading to an urgent need for advanced, automated diagnostic tools. The aim of this research is to develop a deep learning-based decision-support system for the microscopic examination of tissue samples to support non-experts with the live diagnosis of the disease. Methods: Tissue samples from lesions were collected from patients diagnosed with cutaneous leishmaniasis in Libya and Palestine for the purpose of preparing microscopic slides. The samples were then visualized using a high-performance laboratory microscope and a mobile, low-cost device. The captured images were subsequently used to train the object detection framework YOLOv8 with the aim of identifying Leishmania parasites. A graphical user interface was developed for the application of the deep learning model, which enables real-time detection of the parasites using a microscope camera, as well as recognition from previously generated images and videos. Results: The deep learning YOLOv8 framework was successfully trained using data generated by the advanced microscope and employed for the detection of Leishmania parasites. Subsequent finetuning with a combined set containing the aforementioned data and microscopic images generated with the low-cost device resulted in a considerable improvement in accuracy. The efficacy of the model was demonstrated through its successful operation on previously unseen data. Object detection yielded a mean average precision of 0.78 for the combined datasets. The evaluation process for determining the presence of parasites in an image resulted in 91% accuracy, 91% sensitivity, 90% specificity and 94% precision on the test data. Conclusions: Deep learning-based YOLOv8 achieved accurate Leishmania detection in tissue samples, enhancing decision-support for non-experts via real-time graphical user interface support. This innovation can simplify diagnostics by addressing traditional method limitations, enabling early, accessible leishmaniasis detection in resource-limited settings, and potentially inspiring similar applications in other parasitic diseases. Clinical trial number: Not applicable.
Numerous applications in research and medicine rely on reliable identification and quantification of virus-infected cells. Current methods either apply reporter viruses, that often differ from clinical isolates (e. g. cell tropism, immune evasion) or staining approaches, that prevent live-cell experiments and may introduce biases through manual counting. We present a deep learning model for the label-free identification of virus-infected cells on light microscopy images (VAIruScope). To overcome limitations, our pipeline enables an automated quantification of virus-infected cells based on the recognition of cytopathic effects. The method was applied to different cell models and four clinically relevant prototype viruses representing RNA- (influenza A virus), DNA- (human cytomegalovirus, herpes simplex virus-1) and retroviruses (human immunodeficiency virus-1). VAIruScope identified infected cells achieving classification accuracies of up to 96 %. As proof-of-concept, the method was validated using electron microscopy for a wild-type HSV-1. VAIruScope may be applicable to live-cell imaging to investigate infection dynamics.